The Surgical Resection Difficulty From Neoadjuvant Chemoimmunotherapy Is Minimal and Neoadjuvant Therapy Should Be the Standard

J Thorac Oncol. 2024 Jun;19(6):862-865. doi: 10.1016/j.jtho.2024.03.004.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Immunotherapy* / methods
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery
  • Lung Neoplasms / therapy
  • Neoadjuvant Therapy* / methods